Physician profile
William Colman
NPI 1386664480
$27,078.77
in general payments reported to CMS, 2019-2025
16 companies · $6,408 in 2025
The $6,408 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $213 · 2021: $83.52 · 2022: $67.45 · 2023: $11K · 2024: $9,200 · 2025: $6,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $26K · Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $26,030.27 |
| Food and Beverage | $418.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $26,125.28 | 2019-2025 | Djo Surgical |
| Endo USA, INC. | $215.09 | 2024-2025 | Xiaflex |
| Depuy Synthes Sales INC. | $115.97 | 2019-2025 | Velys |
| Fidia Pharma USA INC. | $81.84 | 2019-2021 | |
| Gotham Surgical Solutions & Devices, INC. | $75.38 | 2020 | |
| Djo, LLC | $72.57 | 2023-2025 | Cmf |
| Smith+Nephew, INC. | $68.02 | 2019-2025 | T-Max |
| Si-Bone, INC. | $67.45 | 2022 | |
| Maxx Orthopedics, INC. | $49.17 | 2020 | |
| Medtronic Vascular, INC. | $44.57 | 2019 | |
| Endo Pharmaceuticals INC. | $35.51 | 2019-2021 | |
| Heron Therapeutics, INC. | $30.85 | 2021 | |
| Pacira Therapeutics, INC. | $26.93 | 2020 | |
| Arbor Pharmaceuticals, INC. | $26.27 | 2020-2021 | |
| Ge Healthcare | $24.88 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $18.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Colman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.